nach oben

Current Neurology and Neuroscience Reports

Erschienen in:

01.01.2019 | Neurology of Systemic Diseases (J Biller, Section Editor)

Neurological Complications of Cardiological Interventions

Erschienen in: Current Neurology and Neuroscience Reports | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Neurological complications are common during cardiac procedures. The type of procedure influences the profile of neurological complications and their management. In this article, we review the different neurological complications encountered following cardiac procedures, and treatment strategies for managing those complications.

Recent Findings

Recent clinical trials have expanded the time window of eligibility for mechanical thrombectomy and intravenous thrombolysis. As a result, more options are now available for the treatment of periprocedural strokes.

Summary

Early recognition of neurological complications, particularly stroke, will allow more patients to be treated effectively. The expanded window for intravenous thrombolysis and mechanical thrombectomy using advanced neuroimaging for selection provides more opportunities for treatment of periprocedural stroke. There is a paucity of data on the management of cerebrovascular complications, such as ischemic and hemorrhagic strokes, in the setting of left ventricular assist device or mechanical valve.

Gottesman RF, McKhann GM, Hogue CW. Neurological complications of cardiac surgery. Semin Neurol. 2008;28(5):703–15.PubMedPubMedCentralCrossRef

Shah R, Morsy MS, Weiman DS, Vetrovec GW. Meta-analysis comparing coronary artery bypass grafting to drug-eluting stents and to medical therapy alone for left main coronary artery disease. Am J Cardiol. 2017;120(1):63–8.PubMedCrossRef

Devgun JK, Gul S, Mohananey D, Jones BM, Hussain MS, Jobanputra Y, et al. Cerebrovascular events after cardiovascular procedures: risk factors, recognition, and prevention strategies. J Am Coll Cardiol. 2018;71(17):1910–20.PubMedCrossRef

Stone GW, Sabik JF, Serruys PW, Kappetein AP. Everolimus-eluting stents or bypass surgery for left main coronary disease. N Engl J Med. 2017;376(11):1089.PubMed

• Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360(10):961–72 SYNTAX trial was one of the major trials to compare the adverse events following coronary artery bypass grafting and percutaneous coronary intervention. PubMedCrossRef

Kowalewski M, Pawliszak W, Malvindi PG, Bokszanski MP, Perlinski D, Raffa GM, et al. Off-pump coronary artery bypass grafting improves short-term outcomes in high-risk patients compared with on-pump coronary artery bypass grafting: meta-analysis. J Thorac Cardiovasc Surg. 2016;151(1):60–77 e1–58.PubMedCrossRef

Kenaan M, Seth M, Aronow HD, Wohns D, Share D, Gurm HS, et al. The clinical outcomes of percutaneous coronary intervention performed without pre-procedural aspirin. J Am Coll Cardiol. 2013;62(22):2083–9.PubMedCrossRef

Aradi D, Komocsi A, Vorobcsuk A, Serebruany VL. Impact of clopidogrel and potent P2Y 12 -inhibitors on mortality and stroke in patients with acute coronary syndrome or undergoing percutaneous coronary intervention: a systematic review and meta-analysis. Thromb Haemost. 2013;109(1):93–101.PubMedCrossRef

Kahlert P, Knipp SC, Schlamann M, Thielmann M, Al-Rashid F, Weber M, et al. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation. 2010;121(7):870–8.PubMedCrossRef

10.

Eggebrecht H, Schmermund A, Voigtlander T, Kahlert P, Erbel R, Mehta RH. Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. EuroIntervention. 2012;8(1):129–38.PubMedCrossRef

11.

Hahn RT, Pibarot P, Webb J, Rodes-Cabau J, Herrmann HC, Williams M, et al. Outcomes with post-dilation following transcatheter aortic valve replacement: the PARTNER I trial (placement of aortic transcatheter valve). JACC Cardiovasc Interv. 2014;7(7):781–9.PubMedCrossRef

12.

Athappan G, Gajulapalli RD, Sengodan P, Bhardwaj A, Ellis SG, Svensson L, et al. Influence of transcatheter aortic valve replacement strategy and valve design on stroke after transcatheter aortic valve replacement: a meta-analysis and systematic review of literature. J Am Coll Cardiol. 2014;63(20):2101–10.PubMedCrossRef

13.

Jones BM, Tuzcu EM, Krishnaswamy A, Kapadia SR. Neurologic events after transcatheter aortic valve replacement. Interv Cardiol Clin. 2015;4(1):83–93.PubMed

14.

Nombela-Franco L, Webb JG, de Jaegere PP, Toggweiler S, Nuis RJ, Dager AE, et al. Timing, predictive factors, and prognostic value of cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantation. Circulation. 2012;126(25):3041–53.PubMedCrossRef

15.

Bagur R, Solo K, Alghofaili S, Nombela-Franco L, Kwok CS, Hayman S, et al. Cerebral embolic protection devices during transcatheter aortic valve implantation: systematic review and meta-analysis. Stroke. 2017;48(5):1306–15.PubMedCrossRef

16.

Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(22):2438–88.PubMedCrossRef

17.

Aryal MR, Karmacharya P, Pandit A, Hakim F, Pathak R, Mainali NR, et al. Dual versus single antiplatelet therapy in patients undergoinHeart Lung Circg transcatheter aortic valve replacement: a systematic review and meta-analysis. 2015;24(2):185–92.

18.

Messe SR, Acker MA, Kasner SE, Fanning M, Giovannetti T, Ratcliffe SJ, et al. Stroke after aortic valve surgery: results from a prospective cohort. Circulation. 2014;129(22):2253–61.PubMedPubMedCentralCrossRef

19.

Hauville C, Ben-Dor I, Lindsay J, Pichard AD, Waksman R. Clinical and silent stroke following aortic valve surgery and transcatheter aortic valve implantation. Cardiovasc Revasc Med. 2012;13(2):133–40.PubMedCrossRef

20.

Baber U, van der Zee S, Fuster V. Anticoagulation for mechanical heart valves in patients with and without atrial fibrillation. Curr Cardiol Rep. 2010;12(2):133–9.PubMedCrossRef

21.

Arnold AZ, Mick MJ, Mazurek RP, Loop FD, Trohman RG. Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter. J Am Coll Cardiol. 1992;19(4):851–5.PubMedCrossRef

22.

Hellman T, Kiviniemi T, Vasankari T, Nuotio I, Biancari F, Bah A, et al. Prediction of ineffective elective cardioversion of atrial fibrillation: a retrospective multi-center patient cohort study. BMC Cardiovasc Disord. 2017;17(1):33.PubMedPubMedCentralCrossRef

23.

Jaakkola S, Kiviniemi TO, Airaksinen KEJ. Cardioversion for atrial fibrillation—how to prevent thromboembolic complications? Ann Med. 2018:1–7.

24.

Cote G, Denault A. Transesophageal echocardiography-related complications. Can J Anaesth. 2008;55(9):622–47.PubMedCrossRef

25.

Kislitsina ON, Anderson AS, Rich JD, Vorovich EE, Pham DT, Cox JL, et al. Strokes associated with left ventricular assist devices. J Card Surg. 2018;33(9):578–83.PubMedCrossRef

26.

Cho SM, Moazami N, Frontera JA. Stroke and intracranial hemorrhage in HeartMate II and HeartWare left ventricular assist devices: a systematic review. Neurocrit Care. 2017;27(1):17–25.PubMedCrossRef

27.

Blitz A. Pump thrombosis—a riddle wrapped in a mystery inside an enigma. Ann Cardiothorac Surg. 2014;3(5):450–71.PubMedPubMedCentral

28.

•• Thomalla G, Simonsen CZ, Boutitie F, Andersen G, Berthezene Y, Cheng B, et al. MRI-guided thrombolysis for stroke with unknown time of onset. N Engl J Med. 2018;379(7):611–22 WAKE-UP trial investigated the use of IV-tPA guided by a mismatch between diffusion weighted imaging and FLAIR in the region of ischemia and showed a significantly better functional outcome compared to placebo. PubMedCrossRef

29.

Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2018;49(3):e46–e110.PubMedCrossRef

30.

•• Nogueira RG, Jadhav AP, Haussen DC, Bonafe A, Budzik RF, Bhuva P, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018;378(1):11–21 DAWN trial showed a significant benefit for using of mechanical thrombectomy for patients who met specific criteria up to 24 hours. PubMedCrossRef

31.

•• Albers GW, Marks MP, Kemp S, Christensen S, Tsai JP, Ortega-Gutierrez S, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med. 2018;378(8):708–18 DEFUSE trial showed a significant benefit for using of mechanical thrombectomy for patients who met specific criteria up to 16 hours. PubMedPubMedCentralCrossRef

32.

Holzmann MJ, Ahlback E, Jeppsson A, Sartipy U. Renal dysfunction and long-term risk of ischemic and hemorrhagic stroke following coronary artery bypass grafting. Int J Cardiol. 2013;168(2):1137–42.PubMedCrossRef

33.

Stewart RA. Clinical trials in heart valve disease. Curr Opin Cardiol. 2009;24(4):279–87.PubMedCrossRef

34.

Suarez J, Patel CB, Felker GM, Becker R, Hernandez AF, Rogers JG. Mechanisms of bleeding and approach to patients with axial-flow left ventricular assist devices. Circ Heart Fail. 2011;4(6):779–84.PubMedCrossRef

35.

Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361(23):2241–51.PubMedCrossRef

36.

Hemphill JC 3rd, Greenberg SM, Anderson CS, Becker K, Bendok BR, Cushman M, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46(7):2032–60.PubMedCrossRef

37.

Kuramatsu JB, Gerner ST, Schellinger PD, Glahn J, Endres M, Sobesky J, et al. Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage. JAMA. 2015;313(8):824–36.PubMedCrossRef

38.

Majeed A, Kim YK, Roberts RS, Holmstrom M, Schulman S. Optimal timing of resumption of warfarin after intracranial hemorrhage. Stroke. 2010;41(12):2860–6.PubMedCrossRef

39.

Kuramatsu JB, Sembill JA, Gerner ST, Sprugel MI, Hagen M, Roeder SS, et al. Management of therapeutic anticoagulation in patients with intracerebral haemorrhage and mechanical heart valves. Eur Heart J. 2018;39(19):1709–23.PubMedPubMedCentralCrossRef

40.

Halvorsen S, Storey RF, Rocca B, Sibbing D, Ten Berg J, Grove EL, et al. Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on thrombosis. Eur Heart J. 2017;38(19):1455–62.PubMed

41.

Tahir RA, Rotman LE, Davis MC, Dupepe EB, Kole MK, Rahman M, et al. Intracranial hemorrhage in patients with a left ventricular assist device. World Neurosurg. 2018;113:e714–e21.PubMedCrossRef

42.

Wong JK, Chen PC, Falvey J, Melvin AL, Lidder AK, Lowenstein LM, et al. Anticoagulation reversal strategies for left ventricular assist device patients presenting with acute intracranial hemorrhage. ASAIO J. 2016;62(5):552–7.PubMedCrossRef

43.

Wilson TJ, Stetler WR Jr, Al-Holou WN, Sullivan SE, Fletcher JJ. Management of intracranial hemorrhage in patients with left ventricular assist devices. J Neurosurg. 2013;118(5):1063–8.PubMedCrossRef

44.

Moulakakis KG, Alexiou VG, Karaolanis G, Sfyroeras GS, Theocharopoulos GN, Lazaris AM, et al. Spinal cord ischemia following elective endovascular repair of Infrarenal aortic aneurysms: a systematic review. Ann Vasc Surg. 2018;52:280–91.PubMedCrossRef

45.

Miyamoto K, Ueno A, Wada T, Kimoto S. A new and simple method of preventing spinal cord damage following temporary occlusion of the thoracic aorta by draining the cerebrospinal fluid. J Cardiovasc Surg. 1960;1:188–97.

46.

Cunningham JN Jr, Laschinger JC, Merkin HA, Nathan IM, Colvin S, Ransohoff J, et al. Measurement of spinal cord ischemia during operations upon the thoracic aorta: initial clinical experience. Ann Surg. 1982;196(3):285–96.PubMedPubMedCentralCrossRef

47.

Newman MF, Kirchner JL, Phillips-Bute B, Gaver V, Grocott H, Jones RH, et al. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med. 2001;344(6):395–402.PubMedCrossRef

48.

Selnes OA, Gottesman RF, Grega MA, Baumgartner WA, Zeger SL, McKhann GM. Cognitive and neurologic outcomes after coronary-artery bypass surgery. N Engl J Med. 2012;366(3):250–7.PubMedCrossRef

49.

Stroobant N, van Nooten G, De Bacquer D, Van Belleghem Y, Vingerhoets G. Neuropsychological functioning 3-5 years after coronary artery bypass grafting: does the pump make a difference? Eur J Cardiothorac Surg. 2008;34(2):396–401.PubMedCrossRef

50.

Kennedy ED, Choy KC, Alston RP, Chen S, Farhan-Alanie MM, Anderson J, et al. Cognitive outcome after on- and off-pump coronary artery bypass grafting surgery: a systematic review and meta-analysis. J Cardiothorac Vasc Anesth. 2013;27(2):253–65.PubMedCrossRef

51.

Goto T, Baba T, Honma K, Shibata Y, Arai Y, Uozumi H, et al. Magnetic resonance imaging findings and postoperative neurologic dysfunction in elderly patients undergoing coronary artery bypass grafting. Ann Thorac Surg. 2001;72(1):137–42.PubMedCrossRef

52.

Boodhwani M, Rubens F, Wozny D, Rodriguez R, Nathan HJ. Effects of sustained mild hypothermia on neurocognitive function after coronary artery bypass surgery: a randomized, double-blind study. J Thorac Cardiovasc Surg. 2007;134(6):1443–50 discussion 51-2.PubMedCrossRef

53.

Nathan HJ, Rodriguez R, Wozny D, Dupuis JY, Rubens FD, Bryson GL, et al. Neuroprotective effect of mild hypothermia in patients undergoing coronary artery surgery with cardiopulmonary bypass: five-year follow-up of a randomized trial. J Thorac Cardiovasc Surg. 2007;133(5):1206–11.PubMedCrossRef

54.

Lai KS, Herrmann N, Saleem M, Lanctot KL. Cognitive outcomes following transcatheter aortic valve implantation: a systematic review. Cardiovasc Psychiatry Neurol. 2015;2015:209569.PubMedPubMedCentralCrossRef

55.

Liimatainen J, Perakyla J, Jarvela K, Sisto T, Yli-Hankala A, Hartikainen KM. Improved cognitive flexibility after aortic valve replacement surgery. Interact Cardiovasc Thorac Surg. 2016;23(4):630–6.PubMedCrossRef

56.

Kocabay G, Karabay CY, Kalayci A, Akgun T, Guler A, Oduncu V, et al. Contrast-induced neurotoxicity after coronary angiography. Herz. 2014;39(4):522–7.PubMedCrossRef

57.

Leong S, Fanning NF. Persistent neurological deficit from iodinated contrast encephalopathy following intracranial aneurysm coiling. A case report and review of the literature. Interv Neuroradiol. 2012;18(1):33–41.PubMedPubMedCentralCrossRef

58.

Guimaraens L, Vivas E, Fonnegra A, Sola T, Soler L, Balaguer E, et al. Transient encephalopathy from angiographic contrast: a rare complication in neurointerventional procedures. Cardiovasc Intervent Radiol. 2010;33(2):383–8.PubMedCrossRef

59.

Tong X, Hu P, Hong T, Li M, Zhang P, Li G, et al. Transient cortical blindness associated with endovascular procedures for intracranial aneurysms. World Neurosurg. 2018;119:123–31.PubMedCrossRef

60.

Zwicker JC, Sila CA. MRI findings in a case of transient cortical blindness after cardiac catheterization. Catheter Cardiovasc Interv. 2002;57(1):47–9.PubMedCrossRef

61.

Lantos G. Cortical blindness due to osmotic disruption of the blood-brain barrier by angiographic contrast material: CT and MRI studies. Neurology. 1989;39(4):567–71.PubMedCrossRef

62.

Sila C. Neurologic complications of cardiac tests and procedures. Handb Clin Neurol. 2014;119:41–7.PubMedCrossRef

63.

Wallach SG. Cannulation injury of the radial artery: diagnosis and treatment algorithm. Am J Crit Care. 2004;13(4):315–9.PubMed

64.

Martin SD, Sharrock NE, Mineo R, Sobel M, Weiland AJ. Acute exacerbation of carpal tunnel syndrome after radial artery cannulation. J Hand Surg [Am]. 1993;18(3):455–8.CrossRef

65.

El-Ghanem M, Malik AA, Azzam A, Yacoub HA, Qureshi AI, Souayah N. Occurrence of femoral nerve injury among patients undergoing Transfemoral percutaneous catheterization procedures in the United States. J Vasc Interv Neurol. 2017;9(4):54–8.PubMedPubMedCentral

66.

Kent KC, Moscucci M, Gallagher SG, DiMattia ST, Skillman JJ. Neuropathy after cardiac catheterization: incidence, clinical patterns, and long-term outcome. J Vasc Surg. 1994;19(6):1008–13 discussion 13-4.PubMedCrossRef

67.

Kent KC, Moscucci M, Mansour KA, DiMattia S, Gallagher S, Kuntz R, et al. Retroperitoneal hematoma after cardiac catheterization: prevalence, risk factors, and optimal management. J Vasc Surg. 1994;20(6):905–10 discussion 10-3.PubMedCrossRef

68.

Dimarakis I, Protopapas AD. Vocal cord palsy as a complication of adult cardiac surgery: surgical correlations and analysis. Eur J Cardiothorac Surg. 2004;26(4):773–5.PubMedCrossRef

Titel: Neurological Complications of Cardiological Interventions
Publikationsdatum: 01.01.2019
Erschienen in: Current Neurology and Neuroscience Reports / Ausgabe 2/2019
Print ISSN: 1528-4042
Elektronische ISSN: 1534-6293
DOI: https://doi.org/10.1007/s11910-019-0923-1

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders scheint das auf weibliche Kranke zuzutreffen, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2019

Neurological Prognostication After Cardiac Arrest in the Era of Target Temperature Management

Sleep Complaints, Sleep and Breathing Disorders in Myotonic Dystrophy Type 2

Therapeutic Hypothermia in Neonatal Hypoxic-Ischemic Encephalopathy

Movement Disorders in Metabolic Disorders

Unbiased Screens for Modifiers of Alpha-Synuclein Toxicity